N
N. Enas
Researcher at Eli Lilly and Company
Publications - 1
Citations - 39
N. Enas is an academic researcher from Eli Lilly and Company. The author has contributed to research in topics: Arzoxifene & Breast cancer. The author has an hindex of 1, co-authored 1 publications receiving 38 citations.
Papers
More filters
Journal ArticleDOI
Randomized, double-blind, multicenter trial comparing two doses of arzoxifene (LY353381) in hormone-sensitive advanced or metastatic breast cancer patients
José Baselga,Antonio Llombart-Cussac,Meritxell Bellet,V. Guillem-Porta,N. Enas,K. Krejcy,Eva Carrasco,L. Kayitalire,M. Kuta,Ana Lluch,P. Vodvarka,Pierre Kerbrat,Moïse Namer,Lubos Petruzelka +13 more
TL;DR: There were no significant differences in efficacy or safety between 20 and 50 mg of arzoxifene, and arz oxifene 20 mg/day was selected for further study in patients with breast cancer.